El interés en corto de Sutro Biopharma da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Sutro Biopharma. Los datos de interés en corto se actualizan cada dos semanas.

Sutro Biopharma (NASDAQ:STRO) Bolsa, Informe de interés en corto

Sutro Biopharma

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Sutro Biopharma Inc

Strong

STRONG GLOBAL ENTMT INC CL A COM VOTING SHS

Stroeer SE & Co KGaA

STROEER SE CO UNSP/ADR by Stroeer SE and Co

Stronghold Digital Mining, Inc. - Class A Common Stock

Stronghold Digital Mining Inc

Stronghold Token

STROUD RESOURCES LTD by Stroud Resources Ltd.

Stroud Resources Ltd

TD Cowen maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Buy and raises the price target from $173 to $176.

News

Price Target

Analyst Ratings

TTWO

TD Cowen Maintains Buy on Take-Two Interactive, Raises Price Target to $176

B. Riley Securities analyst David Bain maintains Full House Resorts (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLL#NASDAQ">FLL</a>) with a Buy and lowers the price target from $9 to $8.

B. Riley Securities Maintains Buy on Full House Resorts, Lowers Price Target to $8

<a href="https://www.youtube.com/watch?v=8rQlEH86FCM" title="https://www.youtube.com/watch?v=8rQlEH86FCM">https://www.youtube.com/watch?v=8rQlEH86FCM</a>

Macro Economic Events

Econ #s

Economics

Federal Reserve

Fed Chair Powell Says If New Fiscal Policy Is Proposed, We Would Model It, Staff Would Brief Us, Try To Get Smart On It; Once A Law Is Changed It Would Go Into The Model, It's A Process That Takes Some Time; Will Look At Net Effect Of Any New Policies On Economy; Right Now There's Nothing To Model; Don't Know What Policies Are; Will Want To See How Long Higher Bond Rates Will Be Maintained; What We Have Seen So Far It's Not A Major Factor

Oppenheimer analyst Rick Schafer maintains Veeco Instruments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VECO#NASDAQ">VECO</a>) with a Outperform and lowers the price target from $45 to $40.

VECO

Oppenheimer Maintains Outperform on Veeco Instruments, Lowers Price Target to $40

Needham analyst Laura Martin maintains CuriosityStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CURI#NASDAQ">CURI</a>) with a Buy and raises the price target from $1.35 to $3.

CURI

Needham Maintains Buy on CuriosityStream, Raises Price Target to $3

Oppenheimer analyst Noah Kaye maintains Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) with a Outperform and raises the price target from $86 to $87.

Oppenheimer Maintains Outperform on Johnson Controls Intl, Raises Price Target to $87

Telsey Advisory Group analyst Dana Telsey maintains Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) with a Outperform and maintains $207 price target.

Telsey Advisory Group Maintains Outperform on Ralph Lauren, Maintains $207 Price Target

The California Department of Financial Protection and Innovation (DFPI) has taken decisive action against BlockFi Lending LLC by revoking its California Financing Law license. This move comes in response to multiple violations identified by<a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41783773/the-future-of-crypto-regulation-under-a-trump-administration-headwinds-are-now-tailwinds"> the regulatory body</a>.
What Happened: The regulatory agency announced its <a href="https://dfpi.ca.gov/2024/11/07/california-dfpi-revokes-crypto-lender-blockfis-finance-lending-license/">decision</a> on Thursday.
The DFPI&#8217;s investigation uncovered several compliance failures by BlockFi. The crypto lender did not evaluate borrowers&#8217; ability to repay loans and charged interest before loan disbursement. 
The DFPI indicated that BlockFi also failed to offer credit counseling, report payment performance to credit bureaus and accurately disclose annual percentage rates (APRs) in its loan documents.
BlockFi, which filed for bankruptcy in 2022 following the collapse of FTX, has agreed to the license revocation and committed to halting unsafe practices.
Benzinga has contacted BlockFi's claims agent, Kroll, for comment.
The DFPI imposed a $175,000 fine for these violations but waived it to prioritize consumer recovery due to BlockFi&#8217;s bankruptcy status.
In February 2022, a consent order was issued by the DFPI to address allegations of BlockFi offering unqualified securities. DFPI Commissioner Clothilde V. Hewlett stressed the importance of adhering to financial laws to safeguard consumers.
The DFPI continues its regulatory oversight of financial services in California, urging all financial entities within the state to comply with regulations. Consumers are encouraged to file complaints online or through a toll-free number.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41803451/bitcoin-spot-etfs-hit-622m-inflows-following-trump-victory">Bitcoin Spot ETFs Hit $622M Inflows Following Trump Victory</a>
Why It Matters: The revocation of BlockFi&#8217;s license by the DFPI is the latest development in a series of challenges faced by the crypto lender. 
In 2023, a New Jersey Bankruptcy Judge ruled that nearly $300 million held in custodial wallets should be returned to BlockFi clients, emphasizing that these assets belong to the customers and not the bankrupt lender&#8217;s estate. 
An additional $375 million that clients attempted to withdraw from BlockFi&#8217;s interest-bearing accounts remains unpaid due to the company&#8217;s financial troubles following the <a href="https://www.benzinga.com/markets/cryptocurrency/23/10/35445270/the-true-cost-of-the-ftx-collapse-how-much-did-sam-bankman-fried-really-make">FTX collapse</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41775353/bitcoin-hits-new-all-time-high-as-donald-trump-wins-second-term-what-now">Bitcoin Hits New All-Time High As Donald Trump Wins Second Term: What Now?</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

BlockFi's Lending License Revoked By California Regulator Over Violations

Oppenheimer analyst Martin Yang maintains Take-Two Interactive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) with a Outperform and raises the price target from $185 to $190.

Oppenheimer Maintains Outperform on Take-Two Interactive, Raises Price Target to $190

Needham analyst Kyle Peterson maintains Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) with a Buy and raises the price target from $1850 to $2500.

FICO

Needham Maintains Buy on Fair Isaac, Raises Price Target to $2500

<a href="https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5" title="https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5">https://www.youtube.com/live/8rQlEH86FCM?si=s1GWbEOy5eqm4Jq5</a>

Fed's Powell Says Change In Statement Omitting Confidence Not Meant To Convey Anything About Stickiness Of Inflation; We Have Gained Confidence On Inflation Moving Toward 2%; We Don't Want To Do A Lot Of Forward Guidance; There Is A Fair Amount Of Uncertainty; Saying 'Further Progress' Suggests We Are Setting Up A Test;  The Point Is To Find The Right Pace, Need To Find That As We Go

Oppenheimer analyst Martin Yang maintains AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) with a Outperform and raises the price target from $180 to $260.

Oppenheimer Maintains Outperform on AppLovin, Raises Price Target to $260

Jefferies analyst Omar Nokta maintains International Seaways (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSW#NYSE">INSW</a>) with a Buy and maintains $66 price target.

INSW

Jefferies Maintains Buy on International Seaways, Maintains $66 Price Target

Organon's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OGN#NYSE">OGN</a>) short percent of float has risen 28.4% since its last report. The company recently reported that it has 12.53 million shares sold short, which is 6.51% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.98 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Organon Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731008721_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Organon has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Organon's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Organon's peer group average for short interest as a percentage of float is 4.63%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Organon's Recent Short Interest

Nexalin Technology's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXL#NYSE">NXL</a>) short percent of float has risen 30.38% since its last report. The company recently reported that it has 93 thousand shares sold short, which is 1.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Nexalin Technology Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731008715_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Nexalin Technology has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Nexalin Technology's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Nexalin Technology's peer group average for short interest as a percentage of float is 2.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(NXL) - Analyzing Nexalin Technology's Short Interest

WIIM

MEOH

Methanex shares are trading higher after the company reported better-than-expected Q3 revenue results. UBS maintained a Buy rating on the stock.

Credo Technology Group's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRDO#NYSE">CRDO</a>) short percent of float has fallen 6.93% since its last report. The company recently reported that it has 6.94 million shares sold short, which is 4.97% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.99 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Credo Technology Group Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1731008710_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Credo Technology Group has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Credo Technology Group's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Credo Technology Group's peer group average for short interest as a percentage of float is 4.51%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CRDO

Peering Into Credo Technology Group's Recent Short Interest

Oppenheimer analyst Ken Wong maintains HubSpot (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBS#NYSE">HUBS</a>) with a Outperform and raises the price target from $625 to $740.

HUBS

Oppenheimer Maintains Outperform on HubSpot, Raises Price Target to $740

Fed's Powell Says Not Ruling It Out Or In, When Asked About 2025 Rate Cut Projections From September

PureCycle Technologies shares are trading lower after the company reported worse-than-expected Q3 EPS results.

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Sutro Biopharma (STRO – Research Report). The company's shares c...

TD Cowen Sticks to Its Buy Rating for Sutro Biopharma (STRO)

Sutro Biopharma's Competitive ADCs Position It For Future Growth In Oncology

Sutro Biopharma (STRO – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Reni Benjamin from J...

Sutro Biopharma's Promising ADC Innovations and Strategic Collaborations Justify a Buy Rating

In a report released today, Edward Tenthoff from Piper Sandler reiterated a Buy rating on Sutro Biopharma (STRO – Research Report), with a price ta...

Piper Sandler Sticks to Its Buy Rating for Sutro Biopharma (STRO)

H.C. Wainwright analyst Andrew Fein has maintained their bullish stance on STRO stock, giving a Buy rating today. Andrew Fein has given his Buy rat...

Sutro Biopharma: Poised to Become an ADC Powerhouse with Innovative XpressCF(+) Platform

Truist Financial analyst Asthika Goonewardene assigned a Buy rating to the stock today. The company's shares closed yesterday at $3.31. Goonewarden...

Truist Financial Issues a Buy Rating on Sutro Biopharma (STRO)

In a report released today, David Nierengarten from Wedbush maintained a Buy rating on Sutro Biopharma (STRO – Research Report), with a price targe...

Sutro Biopharma (STRO) Gets a Buy from Wedbush

Sutro Biopharma: Post ESMO Selloff, Does Their Strategy In FRα Remain Viable?

In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Sutro Biopharma (STRO – Research Report). The com...

Truist Financial Reaffirms Their Buy Rating on Sutro Biopharma (STRO)

Sutro Biopharma (STRO) announced that REFRaME-P1, the registration-directed study of luveltamab tazevibulin for pediatric patients with CBFA2T3::GL...

Comments

Sutro Biopharma

Interés en corto

Sutro Biopharma (NASDAQ:STRO) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL